Osteoporosis: Clinical Trials

1,762 trials for Osteoporosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1186 completed, 241 unknown, 100 recruiting, 72 terminated. 524 Not applicable, 243 Phase 3, 220 Phase 4, 183 Phase 2, 126 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable524Completed 341, Unknown 59, Recruiting 42, Not yet recruiting 22, Active not recruiting 21, Terminated 19, Withdrawn 15, Suspended 3, Enrolling by invitation 2
Phase 3243Completed 204, Unknown 18, Terminated 14, Withdrawn 6, Enrolling by invitation 1
Phase 4220Completed 148, Unknown 28, Recruiting 13, Active not recruiting 10, Terminated 8, Not yet recruiting 6, Withdrawn 6, Enrolling by invitation 1
Phase 2183Completed 128, Unknown 21, Terminated 15, Withdrawn 9, Recruiting 4, Not yet recruiting 3, Active not recruiting 2, Enrolling by invitation 1
Phase 1126Completed 92, Unknown 16, Terminated 6, Withdrawn 5, Not yet recruiting 3, Active not recruiting 2, Enrolling by invitation 1, Recruiting 1
Early Phase 17Completed 6, Unknown 1

Follow Osteoporosis: new trials by email Literature Review of Osteoporosis trials Research Report on Osteoporosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMD
Romosozumab, Zoledronic Acid 5 MG in 5 ML Injection, Calcium 500 mg and Vitamin D3 800 IU - Osteoporosis in Post-menopausal Women
Phase 4Not yet recruitingSahlgrenska University Hospital2162027-01-112026-08-19
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
Endothelial cell collection - Obesity and Obesity-related Medical Conditions, Diabetes
RecruitingBettina Mittendorfer1002027-01-012026-05-07
Romosozumab and Denosumab Combination Therapy for Osteoporosis
Romosozumab, Romosozumab and Denosumab - Postmenopausal Osteoporosis
Phase 4Not yet recruitingMassachusetts General Hospital1002027-01-012026-11-03
Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis
Exercise training - Osteopenia, Osteoporosis
Not applicableWithdrawnUniversity of Alabama at Birmingham2026-12-012026-07-01
Exercise and Fall Prevention for Fracture Reduction
Guideline-based home exercise training - Osteopenia, Osteoporosis
Not applicableNot yet recruitingWolfgang Kemmler, PhD722026-11-012026-10-29
Study of TST002 Injection in Postmenopausal Women With Osteoporosis or Low Bone Mass
Denosumab, Placebo - Postmenopausal Osteoporosis, Low Bone Mass
Phase 2Not yet recruitingTranscenta Therapeutics (Hangzhou) Co., Ltd.1102026-10-312026-09-11
Osteoporosis & Renal Disease: Research in Primary Health Care Services
Fracture risk assessment tool (FRAX), Dual-Energy X-ray Absorptiometry (DXA) - Osteoporosis, Chronic Kidney Disease Mineral and Bone Disorder
Not yet recruitingUniversidade do Porto6222026-10-012026-09-30
Controlled Reduction of AO Spine B3 Fractures in Ankylosing Spinal Disorders Using an Inflatable Positioning Device: Technical Note and Retrospective Single-centre Case Series
Spine Fracture, Osteoporosis
Not yet recruitingDiakonie-Klinikum Stuttgart232026-09-202026-09-29
Calcium-Rich Food Versus Calcium Carbonate for Bone Health
500 mg calcium from milk-derived minerals, Calcium Carbonate 500 MG - Osteopenia, Osteoporosis
Not applicableNot yet recruitingCornell University2172026-09-012026-08-13
Romosozumab Versus Denosumab In Glucocorticoid-induced Osteoporosis: An Extended Observation Of a Clinical Trial at 6 Years
Romosozumab, Denosumab - Glucocorticoid-Associated Osteopenia and Osteoporosis
Phase 4Not yet recruitingTuen Mun Hospital542026-09-012026-08-12
Full-Spectrum Cannabis Extract for Chronic Pain and Bone Health Biomarkers in Women
Full-Spectrum Cannabis Extract 5:1 (CBD:THC) - Chronic Pain, Fibromyalgia
Phase 2Not yet recruitingAssociação Pan-Americana Multidisciplinar de Endocanabinologia802026-09-012026-08-26
Post-osteoporotic Fracture Exercise Program
Exercise Program - Osteoporosis, Osteoporotic Fracture
Not applicableNot yet recruitingWestern University, Canada1002026-09-012026-08-20
Effects of Sensorimotor Balance Training vs Digitally Augmented Core Stabilization in Women With Osteoporosis
Sensorimotor-Based Balance Training, Digitally Augmented Core Stabilization - Postmenopausal Osteoporosis
Not applicableNot yet recruitingRiphah International University402026-09-012026-10-15
EFFECTIVENESS AND CLINICAL OPTIMIZATION OF A STANDARDIZED PHYSIOTHERAPY EXERCISE PROGRAM TARGETING BALANCE-POSTURE INTERACTION AND FALL RISK IN OSTEOPOROSIS: A RANDOMIZED CONTROLLED TRIAL
Structured Physiotherapy Exercise Program - Osteoporosis, Risk of Falls
Not applicableNot yet recruitingAlma Mater Europaea - Slovenia882026-09-012026-08-13
Effect of Postural Correction Exercises on Pelvic Floor Dysfunction in Postmenopausal Osteoporotic Women
Estrogen replacement therapy, General advice, Postural correction exercise program - Osteoporosis, Postmenopausal
Not applicableNot yet recruitingCairo University602026-09-012026-09-08
GRACE II (General Retrospective Analysis of Commercial Experience With AGN1 LOEP)
AGN1 LOEP - Osteoporosis
Enrolling by invitationAgNovos Healthcare, LLC3052026-08-252026-10-30
The Relationship Between Lipedema and Osteoporosis
DXA - Lipedema, Osteoporosis
Not yet recruitingFatih Sultan Mehmet Training and Research Hospital1202026-08-202026-08-21
The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation
Ibandronate IV, Zoledronic acid IV - Postmenopausal Osteoporosis, Postmenopausal Osteopenia
Phase 4RecruitingNational Taiwan University Hospital522026-08-202026-08-25
Pharmacokinetics of Zoledronic Acid in Patients on Dialysis
Zoledronic Acid Injection, 5.0 mg, single dose, Zoledronic Acid Injection, 2.5 mg, single dose - Chronic Kidney Disease, Osteoporosis
Phase 1Not yet recruitingUniversity of Campinas, Brazil242026-08-152026-09-10
Validation of a Deep Learning Tool for Opportunistic Osteoporosis Screening Using Routine Non-Contrast CT Scans
DeepBMD model for osteoporosis risk screening - Osteoporosis
Active not recruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology1002026-07-282026-09-03

Showing 20 of 1762. Sign in to see all of them.

Narrower conditions

Osteoporosis, Postmenopausal (332)  ·  Bone Diseases, Metabolic (278)  ·  Fractures, Bone (120)  ·  Sarcopenia (64)  ·  Motor Activity (62)  ·  Osteoporotic Fractures (53)  ·  Hip Fractures (50)  ·  Breast Neoplasms (49)  ·  Diabetes Mellitus (49)  ·  Spinal Fractures (49)  ·  Cardiovascular Diseases (39)  ·  Obesity (39)  ·  Hypertension (29)  ·  Arthritis, Rheumatoid (27)

Broader conditions

Nutritional and Metabolic Diseases (1762)  ·  Metabolic Diseases (1758)  ·  Musculoskeletal Diseases (1742)  ·  Bone Diseases (1735)  ·  Bone Diseases, Metabolic (1484)  ·  Wounds and Injuries (275)  ·  Pathological Conditions, Signs and Symptoms (261)  ·  Signs and Symptoms (169)  ·  Nervous System Diseases (160)  ·  Fractures, Bone (136)  ·  Endocrine System Diseases (123)  ·  Neurologic Manifestations (114)  ·  Pathologic Processes (113)  ·  Neoplasms (103)

Interventions

Denosumab (111)  ·  Alendronate (108)  ·  Teriparatide (103)  ·  Zoledronic Acid (87)  ·  Cholecalciferol (66)  ·  Risedronic Acid (63)  ·  Calcium (60)  ·  Vitamin D (60)  ·  Ibandronic Acid (42)  ·  Exercise (40)  ·  Absorptiometry, Photon (36)  ·  Calcium Carbonate (31)  ·  romosozumab (30)  ·  Raloxifene Hydrochloride (25)  ·  Resistance Training (21)

Sponsors

Eli Lilly and Company (45)  ·  Amgen (41)  ·  National Taiwan University Hospital (32)  ·  GlaxoSmithKline (24)  ·  Hoffmann-La Roche (24)  ·  Merck Sharp & Dohme LLC (24)  ·  Massachusetts General Hospital (21)  ·  Novartis Pharmaceuticals (20)  ·  Organon and Co (18)  ·  University of Aarhus (16)  ·  Sanofi (15)  ·  University of Alabama at Birmingham (14)  ·  Cairo University (12)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (12)  ·  Assistance Publique - Hôpitaux de Paris (11)

Countries

United States (540)  ·  Canada (133)  ·  France (111)  ·  Denmark (93)  ·  China (91)  ·  Turkey (Türkiye) (77)  ·  Italy (71)  ·  United Kingdom (70)  ·  Germany (69)  ·  Taiwan (61)  ·  Spain (59)  ·  Poland (52)  ·  South Korea (47)  ·  Belgium (46)  ·  Australia (44)

Top investigators

Mustafa H Temel, M.D. (10)  ·  Thomas J Schnitzer, MD, PhD (7)  ·  Benjamin Leder, MD (5)  ·  Connie M Weaver, PhD (5)  ·  Ding-Cheng Chan, MD, PhD (5)

Results publications

PMID 38979716, PMID 21037195, PMID 34231877, PMID 31776637, PMID 11138687, PMID 12795371, PMID 16018754, PMID 18539106, PMID 19362675, PMID 20533525, PMID 21062463, PMID 21148044, PMID 21289258, PMID 21544866, PMID 22152181, PMID 23013236, PMID 23803880, PMID 25030780, PMID 25179289, PMID 25475435, PMID 25527752, PMID 26869384, PMID 27072861, PMID 27385761, PMID 27557655, PMID 27680993, PMID 28473464, PMID 28487349, PMID 28546097, PMID 29105841, PMID 29141853, PMID 29605469, PMID 29661934, PMID 30334093, PMID 31411768, PMID 31665314, PMID 31674644, PMID 32658264, PMID 33813753, PMID 34717922, PMID 35478046, PMID 35538903, PMID 35712111, PMID 36088628, PMID 36588166, PMID 38573517, PMID 39527056, PMID 39606939, PMID 101855, PMID 10826123

NIH funding

2008 (5), 2009 (5), 2016 (5), 2005 (3), 2018 (3), 2025 (3), P50AR044855 (3), P50AT000090 (3), R44AG017400 (3), 2014 (2), 2015 (2), 2017 (2), N01AR002245 (2), R01DK051081 (2), R01DK073039 (2)